Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/19821
Title: | Use of dipeptidyl peptidase 4 inhibitors and fracture risk compared to use of other anti-hyperglycemic drugs | Authors: | Driessen, Johanna H. M. van Onzenoort, Hein A. W. Starup-Linde, Jakob Henry, Ronald Neef, Cees VAN DEN BERGH, Joop Vestergaard, Peter de Vries, Frank Burden, Andrea M. |
Issue Date: | 2015 | Publisher: | WILEY-BLACKWELL | Source: | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24 (10), p. 1017-1025 | Abstract: | IntroductionDipeptidyl peptidase-4 inhibitors (DPP4-Is) are a new class of anti-hyperglycemic drugs which might have a potential beneficial effect on bone metabolism. Data on the effect of DPP4-I use and fracture risk is limited and conflicting. The aim of the present study was to investigate the association between use of DPP4-Is and fracture risk. MethodsA case-control study was conducted using data from the Danish National Health Service. Cases were those who sustained a fracture, and controls were those without a fracture during the study period (2007-2011), all aged 18years and older. Conditional logistic regression estimated the odds ratios of fracture with current use of DPP4-I use. Analyses were adjusted for comorbidities and recent drug use. ResultsAmong the cases there were 6993 current non-insulin anti-diabetic drug (NIAD) users (excluding incretin users) and 643 DPP4-I users. There were 7209 NIAD users (excluding incretin users) among the controls and 707 DPP4-I users. Current DPP4-I use was not associated with risk of any fracture (adjusted [adj.] OR: 0.97, 95% CI: 0.79-1.18) or major osteoporotic fracture (adj. OR: 0.96, 95% CI: 0.72-1.28). Stratification of current DPP4-I use to cumulative and average daily dose did not show an association. ConclusionsIn a population-based case-control study we identified that short-term use of DPP4-I was not associated with fracture risk as compared to users of other anti-hyperglycemic drugs. Additionally, results suggest that increasing daily dose and cumulative DPP4-I exposure were not associated with fracture risk. However, more research is needed to assess the effect of long-term DPP4-I use on the risk of fracture. Copyright (c) 2015 John Wiley & Sons, Ltd. | Notes: | [Driessen, Johanna H. M.; de Vries, Frank; Burden, Andrea M.] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Driessen, Johanna H. M.; Neef, Cees; de Vries, Frank; Burden, Andrea M.] Care & Publ Hlth Res Inst, Maastricht, Netherlands. [Driessen, Johanna H. M.; van Onzenoort, Hein A. W.; Neef, Cees; de Vries, Frank; Burden, Andrea M.] Maastricht Univ Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands. [van Onzenoort, Hein A. W.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, NL-6525 ED Nijmegen, Netherlands. [Starup-Linde, Jakob; Vestergaard, Peter] Aalborg Univ, Dept Clin Med, Aalborg, Denmark. [Starup-Linde, Jakob] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark. [Henry, Ronald] Maastricht Univ, Med Ctr, Dept Med, NL-6200 MD Maastricht, Netherlands. [Henry, Ronald] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands. [van den Bergh, Joop] Maastricht Univ, Med Ctr, Dept Internal Med, NL-6200 MD Maastricht, Netherlands. [van den Bergh, Joop] Univ Hasselt, Biomed Res Inst, Hasselt, Belgium. [Vestergaard, Peter] Aalborg Univ Hosp, Dept Endocrinol, Aalborg, Denmark. [de Vries, Frank] Southampton Gen Hosp, MRC Epidemiol Lifecourse Unit, Southampton SO9 4XY, Hants, England. | Keywords: | DPP4-I; fracture; type 2 diabetes mellitus; case–control; pharmacoepidemiology;DPP4-I; fracture; type 2 diabetes mellitus; case-control; pharmacoepidemiology | Document URI: | http://hdl.handle.net/1942/19821 | ISSN: | 1053-8569 | e-ISSN: | 1099-1557 | DOI: | 10.1002/pds.3837 | ISI #: | 000362408900002 | Rights: | Copyright © 2015 John Wiley & Sons, Ltd. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2016 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
driessen 1.pdf Restricted Access | Published version | 104.79 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
14
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
23
checked on Apr 22, 2024
Page view(s)
90
checked on Sep 6, 2022
Download(s)
62
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.